Advances in mucoadhesive and mucus-penetrating materials, nano-formulations, and in situ gelling systems for nasal drug delivery

[thumbnail of Open Access]
Preview
Text (Open Access)
- Published Version
· Available under License Creative Commons Attribution.
[thumbnail of EODD-2025-ST-0508.R2-accepted-final.docx]
Text
- Accepted Version
· Restricted to Repository staff only

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Porfiryeva, N. N., Moustafine, R. I. and Khutoryanskiy, V. ORCID: https://orcid.org/0000-0002-7221-2630 (2026) Advances in mucoadhesive and mucus-penetrating materials, nano-formulations, and in situ gelling systems for nasal drug delivery. Expert Opinion on Drug Delivery. ISSN 1744-7593 doi: 10.1080/17425247.2026.2628612

Abstract/Summary

Introduction Intranasal drug delivery is increasingly valued not only for local therapy but also as a noninvasive route that can bypass the blood – brain barrier, enabling rapid treatment of neurological and systemic diseases. However, mucociliary clearance and limited epithelial absorption often reduce residence time and bioavailability, creating a need for more effective formulation strategies. Mucoadhesive and mucus-penetrating systems are among the most promising approaches. Areas covered This review summarizes nasal anatomical and physiological features that govern interactions between formulations and the mucosa. It overviews representative intranasal dosage forms (liquids, powders, gels, films, in situ gelling systems, and nano-formulations). Polymers used as mucoadhesive agents are classified into first- and second-generation materials, which enhance adhesion through hydrogen bonding, electrostatic interactions, or covalent attachment. The review also highlights polymers applied to nanoparticle surfaces to facilitate diffusion through mucus and improve epithelial access. Finally, methods to evaluate mucoadhesion and toxicity are outlined, including alternative in vitro and in vivo models. Expert opinion Recent advances have expanded nasal delivery options, particularly for nose-to-brain targeting. Yet translation remains limited by insufficient validation, long-term safety uncertainties, and repeated-dose effects. Future progress requires balancing adhesion with penetration, robust toxicology, and integration of innovative polymers with optimized devices.

Altmetric Badge

Dimensions Badge

Item Type Article
URI https://centaur.reading.ac.uk/id/eprint/128454
Identification Number/DOI 10.1080/17425247.2026.2628612
Refereed Yes
Divisions Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Pharmaceutics Research Group
Publisher Taylor and Francis
Download/View statistics View download statistics for this item

Downloads

Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record